Gross Profit - Shilpa Medicare Ltd (NSE:SHILPAMED) - Alpha Spread

Shilpa Medicare Ltd
NSE:SHILPAMED

Watchlist Manager
Shilpa Medicare Ltd Logo
Shilpa Medicare Ltd
NSE:SHILPAMED
Watchlist
Price: 802.3 INR -0.42% Market Closed
Market Cap: 78.5B INR
Have any thoughts about
Shilpa Medicare Ltd?
Write Note

Shilpa Medicare Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shilpa Medicare Ltd
Gross Profit Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Shilpa Medicare Ltd
NSE:SHILPAMED
Gross Profit
â‚ą7.7B
CAGR 3-Years
7%
CAGR 5-Years
11%
CAGR 10-Years
11%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Gross Profit
â‚ą205B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Gross Profit
â‚ą173.6B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
10%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Gross Profit
â‚ą386.3B
CAGR 3-Years
14%
CAGR 5-Years
12%
CAGR 10-Years
10%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Gross Profit
â‚ą144.8B
CAGR 3-Years
13%
CAGR 5-Years
11%
CAGR 10-Years
12%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Gross Profit
â‚ą82.7B
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
10%

See Also

What is Shilpa Medicare Ltd's Gross Profit?
Gross Profit
7.7B INR

Based on the financial report for Jun 30, 2024, Shilpa Medicare Ltd's Gross Profit amounts to 7.7B INR.

What is Shilpa Medicare Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
11%

Over the last year, the Gross Profit growth was 19%. The average annual Gross Profit growth rates for Shilpa Medicare Ltd have been 7% over the past three years , 11% over the past five years , and 11% over the past ten years .

Back to Top